Codiak BioSciences, Inc. — Form D
Codiak BioSciences, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-30. The offering totals $76.5M. Industry: Biotechnology.
Offering
- Filed: 2017-11-30
- Form: D
- Accession: 0001659352-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $76.5M
- Remaining: $76.5M
- Investors: 19
- Date of first sale: 2017-11-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-299819
Issuer
- Name: Codiak BioSciences, Inc.
- CIK: 0001659352
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 500 Technology Square, 9th Floor, Cambridge, MA, 02139
- Phone: 857-400-4222
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Noubar Afeyan | Director | Cambridge, MA |
| Charles L Cooney | Director | Cambridge, MA |
| Steven Gillis | Director | South San Francisco, CA |
| Raghu Kalluri | Director | Cambridge, MA |
| Eric Lander | Director | Cambridge, MA |
| Doug Williams | Director | New York, NY |
| Doug Williams | Executive Officer | New York, NY |
Other filings by this issuer (1)
More